Clinical trial
SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
NCT00060099 · Dana-Farber/Brigham and Women's Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00060099 |
|---|---|
| Title | SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia |
| Official title | Phase II Randomized, Double-Blinded Trial Of SGN-00101 (HSP-E7) For Treatment Of CIN II/III |
| Lead sponsor | Dana-Farber/Brigham and Women's Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Precancerous Condition |
| Intervention type | Biological |
| Interventions | HspE7 |
| Start date | May 1, 2003 |
| First posted | May 7, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: